Ercros, S.A. (LON:0M0E)
3.160
-0.010 (-0.32%)
At close: Nov 6, 2025
Ercros Revenue
Ercros had revenue of 168.01M EUR in the quarter ending June 30, 2025, a decrease of -5.34%. This brings the company's revenue in the last twelve months to 654.67M, down -0.39% year-over-year. In the year 2024, Ercros had annual revenue of 668.22M, down -8.00%.
Revenue (ttm)
654.67M EUR
Revenue Growth
-0.39%
P/S Ratio
0.46
Revenue / Employee
496.72K EUR
Employees
1,318
Market Cap
255.96M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 668.22M | -58.07M | -8.00% |
| Dec 31, 2023 | 726.29M | -299.38M | -29.19% |
| Dec 31, 2022 | 1.03B | 236.12M | 29.91% |
| Dec 31, 2021 | 789.55M | 218.47M | 38.26% |
| Dec 31, 2020 | 571.07M | -99.62M | -14.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |